Gomes Filho, Sandro Mascena; Santos, Edmilson Ozorio dos; Bertoldi, Ester Risério Matos; Scalabrini, Luiza Coimbra; Heidrich, Vitor; Dazzani, Bianca; Levantini, Elena; Reis, Eduardo Moraes 
; Bassères, Daniela Sanchez
Source: Cellular Oncology. Unidades: IQ, BIOINFORMÁTICA
Subjects: NEOPLASIAS PANCREÁTICAS, BIOMARCADORES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GOMES FILHO, Sandro Mascena et al. Aurora A kinase and its activator TPX2 are potential therapeutic targets in KRAS-induced pancreatic cancer. Cellular Oncology, v. 43, p. 445–460, 2020Tradução . . Disponível em: https://doi.org/10.1007/s13402-020-00498-5. Acesso em: 14 nov. 2024.APA
Gomes Filho, S. M., Santos, E. O. dos, Bertoldi, E. R. M., Scalabrini, L. C., Heidrich, V., Dazzani, B., et al. (2020). Aurora A kinase and its activator TPX2 are potential therapeutic targets in KRAS-induced pancreatic cancer. Cellular Oncology, 43, 445–460. doi:10.1007/s13402-020-00498-5NLM
Gomes Filho SM, Santos EO dos, Bertoldi ERM, Scalabrini LC, Heidrich V, Dazzani B, Levantini E, Reis EM, Bassères DS. Aurora A kinase and its activator TPX2 are potential therapeutic targets in KRAS-induced pancreatic cancer [Internet]. Cellular Oncology. 2020 ; 43 445–460.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1007/s13402-020-00498-5Vancouver
Gomes Filho SM, Santos EO dos, Bertoldi ERM, Scalabrini LC, Heidrich V, Dazzani B, Levantini E, Reis EM, Bassères DS. Aurora A kinase and its activator TPX2 are potential therapeutic targets in KRAS-induced pancreatic cancer [Internet]. Cellular Oncology. 2020 ; 43 445–460.[citado 2024 nov. 14 ] Available from: https://doi.org/10.1007/s13402-020-00498-5
